PROCEPT BioRobotics (PRCT) Non-Current Deffered Revenue (2023)
PROCEPT BioRobotics' (PRCT) quarterly Non-Current Deffered Revenue came in at $517000.0 in Q3 2023, up 44.82% quarter-over-quarter from $357000.0 in Q2 2023.
Powered by 
Analysis
PROCEPT BioRobotics (PRCT) Non-Current Deffered Revenue (2023) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Non-Current Deffered Revenue for 1 consecutive years, with $517000.0 the latest figure, recorded in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn | - |